Governance

Dr. Myles Greenberg comes to Alucent Biomedical with more than 20 years of experience in growing healthcare, medical technology and life sciences firms as an entrepreneur, operating executive, board member, clinician and investor. Prior to joining Alucent, he served as chief development officer at IntegraMed America, a private equity backed healthcare services firm. Previously, Dr. Greenberg spent most of his career as an early-stage venture capital investor with CHL Medical Partners, HealthInvest Equity Partners and Pappas Ventures. As a start-up venture investor and board member, he often served as lead director or in an interim management role at many dynamic companies in the biotechnology, medical device, and healthcare services sectors, such as Angiomics (acquired by PDL BioPharma), Flowcardia (acquired by CR Bard), Liposcience (acquired by LabCorp), Millennium Pharmacy Systems (acquired by PharMerica), Oriel Therapeutics (acquired by Novartis / Sandoz), NuVasive (Nasdaq: NUVA), Syntonix Pharmaceuticals (acquired by Biogen Idec), and Vascular Pathways (acquired by CR Bard). In addition to leading the Alucent team, Dr. Greenberg currently serves on the board of directors of Urgent Care Centers of New England (d/b/a CareWell Urgent Care), a company he co-founded, and as Entrepreneur-In-Residence at the University of Utah Center for Medical Innovation. Dr. Greenberg began his career as a faculty physician and hospital administrator at Beth Israel Deaconess Medical Center / Harvard Medical School in Boston. He holds a Master of Business Administration from Harvard Business School, Doctor of Medicine from Yale University School of Medicine and a Bachelor of Applied Science from the University of Pennsylvania School of Engineering and Applied Science and is a Diplomate of the American Board of Emergency Medicine.

Brad graduated from BYU with a degree in Mechanical Engineering. He started ATL Technology in 1993 with the first biotech project in 2001. The company is now over 85% medical doing business with eight of the top ten medical device companies. Brad is a private pilot flying both helicopter and airplanes with over 4,200 hours. He is married to Shannon Brown and is the proud father of six children and two grandchildren.

Nate Arnim is a Utah native with BS and MS degrees in Mechanical Engineering from the University of Utah. He has had the pleasure of working for Edwards for 17 years with key positions in R&D, manufacturing engineering, and operations. His passion is to put patients first while leading large scale manufacturing and new product launches of the highest quality, industry leading products in structural heart disease.

Erin E. Barry is VP of Government Affairs for Merit Medical Systems headquartered in South Jordan, Utah. As head of Government Affairs, Ms. Barry oversees all Company local, state, and federal government relations in jurisdictions in which Merit has manufacturing facilities or sales offices. These include the states of Utah, Texas, Virginia, California, Pennsylvania, and Massachusetts and the countries of The US, Ireland, The Netherlands, France, Singapore, Australia, and Mexico.

Ms. Barry directs all state and federal lobbying efforts on key issues including taxation, international trade & tariffs, FDA regulation, and state and local economic incentives and compliance.

Prior to joining Merit in 2015, Ms. Barry was Deputy Director of Government Affairs for the National Air Traffic Controllers (NATCA) where she was responsible for Congressional outreach and lobbying efforts. Prior to NATCA, Ms. Barry was Vice President is Government Affairs for Unspam, a technology startup offering unique filtering software to state governments to protect minors from inappropriate Internet content.

Ms. Barry has a Bachelors Degree in Political Science and Media and Politics from Northwestern University in Evanston, Illinois.

Ms. Barry lives in Park City with her husband, Greg Fredde, and their two young children. 

Kate is an inspirational and strategic leader with over 20 years of progressive career experience in the healthcare industry. Known as a change agent who can encourage positive, customer-focused cultures that create innovative solutions while producing solid market growth, Kate is exceptionally gifted in creating high performing global teams. She has lived in the US and Asia, and has traveled to and met with customers extensively in both developed and emerging markets throughout the world.

Kolby Day joined PolarityTE in 2018. He leads manufacturing, supply chain, logistics, engineering & device development, and quality control testing. He leads the chemistry, manufacturing, and control (CMC) development work for SkinTE. He brings over 18 years of experience in cell therapy and device development. He has developed over 14 products in multiple markets, cell therapy, orthopedics, plastics, wound care, and bone marrow transplant. Prior to joining PolarityTE, Kolby was the VP/General Manager at Arteriocyte Medical Systems (now ISTO Biologics) and Arteriocyte, Inc. (now Compass Biomedical), where he successfully raised over $55 million in capital, functioned as Principle Investigator (or Co-PI) on multiple NIH SBIR, DOD, and BARDA grant awards. He is an inventor on two U.S. Patents. Kolby earned a Juris Doctor from Case Western Reserve University, and a Bachelor of Biology from Southern Utah University.

Keith Marmer serves as chief innovation & economic engagement officer at the University of Utah. In this role, Keith has transformed the culture of commercialization at University of Utah, launching three accelerators, a business incubator and a venture fund to support startup companies. His strong leadership skills come from 30 years of experience as an inventor, entrepreneur and investor. He has three patents, launched three companies, and helped entrepreneurs raise more than $1 billion in investment capital. Previously, Keith was co-founder and managing director of SG3 Ventures, a venture capital fund focused on early-stage life science companies. Prior to SG3 Ventures, Keith was chief business officer at Penn Center for Innovation, University of Pennsylvania. Before his university-based commercialization roles, he was an entrepreneur, founding and scaling two companies and co-founding a consulting firm that advised early-stage growth companies. Across his career, Keith has launched, help to launch or overseen teams responsible for starting more than 140 companies. Keith serves, and has served on numerous corporate and non-profit boards and is a past entrepreneur-in-residence at Princeton University. He received an MBA, Doctor of Physical Therapy, Master of Physical Therapy and Bachelor of Science in Health Sciences from University of the Sciences.

Bo works at Intermountain Health as a Partner in the Strategy Office.  In this role, Bo leads enterprise strategy, business development, and innovation initiatives in partnership with caregiver teams across the organization.

Prior to Intermountain Health, Bo spent 9 years with Leavitt Partners where he was the Managing Principal of the Leavitt Partners’ Salt Lake City office.  In this role, Bo was responsible to lead consultants and serve clients around the country who sought help developing strategic growth plans and executing on projects aligned to advancing value in healthcare.

Bo completed his master’s degree in healthcare management at Yale University and earned his bachelor’s in business from Utah State University.  Bo married his high school sweetheart, Katie, and together they have five children.

Michael was born and raised in Los Angeles, CA and graduated cum laude from the University of Utah in 2004 with a BS in Finance. Michael has worked for Zions Bank since 2011, and is currently a Corporate Banking Portfolio Manager responsible for a $425 million portfolio consisting of businesses in the medical, energy, and construction industries, to name a few. In his spare time, Michael enjoys playing the guitar, skiing, and traveling to Europe.

Dr. Rasmussen co-founded BioFire Diagnostics (then Idaho Technology) in 1990. He served as Chief Operating Officer from 1999 to 2008 and President from 2008 to 2014. Dr. Rasmussen became Chief Executive Officer of BioFire Diagnostics after the acquisition of BioFire by BioMérieux in January of 2014. Dr. Rasmussen was previously with ARUP Laboratories as Medical Director from 1996 to 1999. He also held positions at the University of Utah Cardiology Department and Cardiovascular Pharmacology and Engineering Consultants. Dr. Rasmussen is an inventor on over 20 patents in the fields of real-time PCR, sample-to-answer molecular diagnostics and syndromic testing for infectious diseases. Dr. Rasmussen has a Ph.D. in Biology from the University of Utah and a B.S in Biochemistry from Utah State University.

Jacey Skinner is a government relations lawyer who has held a variety of senior leadership roles in Utah state government. Before joining Ballard Spahr, she served as General Counsel to Governor Gary R. Herbert. In that role, she negotiated legislation, oversaw the Governor’s legislative review and bill signing, coordinated litigation with the Attorney General’s Office, advised the Governor, his cabinet, and the Lieutenant Governor on legal, policy, and ethical issues, and oversaw Gov. Herbert’s judicial appointment process. She has also served as the Deputy State Court Administrator for the State of Utah, where she facilitated policy development and managed relations with the state legislature, executive branch agencies, the Utah Judicial Council, and the Utah Supreme Court. Her experience additionally includes serving as Director of the Utah Sentencing Commission and President of the National Association of Sentencing Commissions, where she oversaw sentencing guidelines, assisted with judicial appointments, and advised the legislature, judiciary, and Governor’s Office on sentencing policy. Jacey was a Deputy District Attorney from 2003 to 2009 at the Salt Lake County District Attorney’s office, where she tried both felony and juvenile cases and oversaw policy development and advocacy as Vice Chair of the Statewide Association of Prosecutors Legislative Action Committee.

Jeffrey J. Kimbell, President of Jeffrey J. Kimbell & Associates, represents 50 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the fifteen-person firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

A graduate of Southern Methodist University (SMU) in Dallas, TX, Mr. Kimbell earned his B.A. in Political
Science. While at SMU, he worked for U.S. Congressman Sam Johnson (R-TX), a member of the House
Ways & Means Committee, which has jurisdiction over tax, trade, and a significant portion of Medicare.

Mr. Kimbell, his wife Jessica, and their three children are avid sportsmen who enjoy fly fishing, hunting, and skiing at locales throughout the world when U.S. Congress is in recess.